(NEW) Updated Stage 1 & Stage 2 Meaningful Use Information for Eligible Hospitals (pdf)
Three of the 10 Meaningful Use menu set objectives specify the electronic reporting of data to public health:
- Submit electronic data to immunization information registry - immunization reporting
- Submit reportable labs results to public health (hospitals only) - laboratory reporting (ELR)
- Submit syndromic surveillance data to public health - syndromic surveillance reporting
In order to meet Meaningful Use requirements, Eligible Professionals and Eligible Hospitals must select five of the menu set requirements, one of which must be a public health reporting options. All electronic reporting must use recommended standards for exchange and vocabulary as shown below in the summary overview of public health Meaningful Use objectives.
Summary Overview of Public Health Meaningful Use Objectives
| Objective |
Eligible Professional (EP) |
Eligible Hospital (EH) |
Recommended Standards |
| Immunization Records |
≥ 1 test of submission to state immunization registry (unless no registries are capable) with continued submission if successful
*See Note #1
|
≥ 1 test of submission to state immunization registry (unless no registries are capable) with continued submission if successful
*See Note #1
|
Use HL7 v2.5.1 specifications but will accept v2.3.1. |
| Reportable Labs |
Not an EP option for Meaningful Use |
≥ 1 test of submission to public health (unless no public health agency is capable) with continued submission if successful |
Follows HL7 v2.5.1 specifications
Implementation guide in development and will be available in Summer 2011
Includes LOINC v2.27 codes
Includes SNOMED codes |
| Syndromic Surveillance |
≥ 1 test of submission to public health (unless no public health agency is capable) with continued submission if successful |
≥ 1 test of submission to public health (unless no public health agency is capable) with continued submission if successful |
HL7 2.3.1
HL7 2.5.1 |
Note 1: For practices (one legal entity) with multiple providers using the same EHR, only one test of submission for each certified EHR system is required.
Example:
| Legal Entities |
Tax ID
|
Eligible Professionals
|
Certified EHRs
|
Tests to Perform
|
| ABC Clinic |
123456789
|
10
|
1
|
1
|
| ZYZ Clinic recent merger with BBB Clinic |
444556666
+
777889999
|
40
|
2
|
2 (one for each Tax ID/EHR system combination)
|
| JJJ Clinic recent merger with AAA Clinic |
111222333
+
444333222
|
33
|
1
|
2 (one for each Tax ID/EHR system combination)
|
| DDD Clinic |
555338888
|
100
|
4
|
4
|
Illinois Department of Public Health - State System Status
| Stage |
State System Status |
| 1 |
Immunizations:
- I-CARE currently accepts immunization data from providers in HL7 2.3.1 and 2.5.1
- I-CARE has been able to accept production level data from providers using HL7 2.3.1 and 2.5.1 since January 1, 2011
- Testing with providers for Meaningful Use is underway
Electronic Laboratory Reporting:
- I-NEDSS currently accepts ELR data from laboratories in a HL7 2.5.1.
- I-NEDSS has been able to accept production level data from providers using HL7 2.5.1 since January 1, 2011
- Testing with providers for Meaningful Use is underway
Syndromic Surveillance
|
Protocol for Public Health and Meaningful Use
Illinois requires all providers seeking attestation to send live production data within 6 months of sending a successful test. IDPH will prioritize resources toward those providers willing to send live production data, in the order in which contact is made and valid data sent. If the provider is not able to send production data within 6 months, then IDPH will work with each provider based on available resources, including the option of using the Illinois Public Health Node to overcome production data challenges. If there are no providers seeking to send live production data in the queue, then IDPH will work with providers seeking only to send test files, in the order in which contact is made. Since the HL7 guide does not specify all the data elements required by the state, providers should reference the implementation guides posted below.
Mission Statement
Review the Illinois HIE Public Health Work Group Mission Statement (pdf).
Electronic Laboratory Reporting
ELR Use Case
This Use Case describes the process for Electronic Laboratory Reporting (ELR), and provides the necessary technical specifications for interoperability between hospitals and reference labs, and the state disease surveillance system, I-NEDSS.
Additional information on this Use Case may be found in this ELR Use Case Document (pdf). Additional information on HL7 can be found at at http://www.hl7.org.
ELR Data Use Agreement
If you want to report Electronic Lab Reporting (ELR) data to IDPH via the IL Public Health Node, please sign a copy of
this Data Use Agreement.
For information on Electronic Lab Testing please contact:
Todd Davis
EDI/ELR Manager
Illinois Department of Public Health
E-mail Todd Davis
(217) 557-0026
Immunization Registry
Immunization Use Case
This Use Case describes the electronic submission of data from a provider's EHR to the state immunization registry (I-CARE), and provides the necessary technical specifications for interoperability.
Additional information on the this Use Case may be found in this Immunization Use Case Document (pdf), the Technical Application of Use Cases FAQs (pdf), and the most recent HL7 specifications, HL7 I-CARE Specs (December 11, 2012).
Immunization Testing Information
Thank you for your interest in I-CARE (Illinois Comprehensive Automated Immunization Registry Exchange) and HL7 data exchange. If you are interested in Meaningful Use (MU), please complete the attached questionnaire. Email it to Igor.Slobodyanyuk@illinois.gov. IDPH will contact you with further details on the MU testing Process.
Once we receive the completed questionnaire it will be placed in a queue. Testing is prioritized based upon the order we receive completed questionnaires. Due to current testing volumes please allow at least 1-2 weeks for a response. An email will be sent to the ‘Site Contact Person’ with test message submission instructions.
For information on Immunization Testing please contact:
HL7 Immunization General Information
Robin Holding
Illinois Department of Public Health
E-mail Robin Holding
(217) 557-0021
HL7 Immunization Technical Information:
Igor Slobodyanyuk
Illinois Department of Public Health
E-mail Igor Slobodyanyuk
(217) 557-0029
Syndromic Surveillance
Syndromic Surveillance Data Use Agreement
If you want to report Syndromic Surveillance data to IDPH via the IL Public Health Node, please sign a copy of
this Data Use agreement.
BioSense Program and Mandate for Syndromic Surveillance:
http://www.cdc.gov/biosense
CDC Syndromic Surveillance Website with Detailed Messaging Guide:
http://www.cdc.gov/ehrmeaningfuluse/syndromic.html
Follow Progress of the BioSense Redesign Project
https://sites.google.com/site/biosenseredesign/about
For information on Syndromic Surveillance Testing please contact:
Mike Jadala
Illinois Public Health Node
E-mail Mike Jadala
Public Health Reporting through ILHIE
Public Health Reporting through ILHIE Webinar (Video and PowerPoint slides)
Centers for Disease Control (CDC) Meaningful Use Information
CDC Meaningful Use